Patents by Inventor Diana Isabel Ruiz

Diana Isabel Ruiz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240100176
    Abstract: The present disclosure provides human interleukin 4 receptor alpha antibody glucocorticoid receptor agonist conjugates and methods of using the conjugates for the treatment of inflammatory diseases, such as type 2 inflammatory diseases.
    Type: Application
    Filed: May 31, 2023
    Publication date: March 28, 2024
    Inventors: Shane Krummen Atwell, Joshua R Clayton, Yiqing Feng, Maya Rachel Karta, Donmienne Doen Mun Leung, Songqing Na, Kristin Paige Newburn, Laura Anne Pelletier, Diana Isabel Ruiz, David John Stokell, Jacqueline M Wurst, Scott Paul Bauer
  • Patent number: 11891441
    Abstract: The present disclosure relates to antibodies that specifically bind human IL-4R?, compositions comprising such IL-4R? antibodies, and methods of using such IL-4R? antibodies.
    Type: Grant
    Filed: August 5, 2022
    Date of Patent: February 6, 2024
    Assignee: ELI LILLY AND COMPANY
    Inventors: Shane Krummen Atwell, Yiqing Feng, Maya Rachel Karta, Donmienne Leung, Songqing Na, Diana Isabel Ruiz, David John Stokell, Laura Anne Pelletier
  • Publication number: 20230064378
    Abstract: The present disclosure relates to antibodies that specifically bind human IL-4R?, compositions comprising such IL-4R? antibodies, and methods of using such IL-4R? antibodies.
    Type: Application
    Filed: August 5, 2022
    Publication date: March 2, 2023
    Inventors: Shane Krummen ATWELL, Yiqing FENG, Maya Rachel KARTA, Donmienne LEUNG, Songqing NA, Diana Isabel RUIZ, David John STOKELL, Laura Anne Pelletier
  • Publication number: 20220251198
    Abstract: The present invention relates to anti-human CD200R agonist antibodies, and uses thereof for treating diseases such as atopic dermatitis, chronic spontaneous urticaria, allergy, asthma, scleroderma, IBD, SLE, MS, RA, GvHD, or psoriasis.
    Type: Application
    Filed: April 21, 2022
    Publication date: August 11, 2022
    Inventors: Stephen J. Demarest, Anja Koester, Scott Charles Potter, Diana Isabel Ruiz, Derrick Ryan Witcher, Xiufeng Wu, Payal Mehta
  • Patent number: 11319370
    Abstract: The present invention relates to anti-human CD200R agonist antibodies, and uses thereof for treating diseases such as atopic dermatitis, chronic spontaneous urticaria, allergy, asthma, scleroderma, IBD, SLE, MS, RA, GvHD, or psoriasis.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: May 3, 2022
    Assignee: Eli Lilly and Company
    Inventors: Stephen J Demarest, Anja Koester, Scott Charles Potter, Diana Isabel Ruiz, Derrick Ryan Witcher, Xiufeng Wu, Payal Mehta
  • Publication number: 20200087395
    Abstract: The present invention relates to anti-human CD200R agonist antibodies, and uses thereof for treating diseases such as atopic dermatitis, chronic spontaneous urticaria, allergy, asthma, scleroderma, IBD, SLE, MS, RA, GvHD, or psoriasis.
    Type: Application
    Filed: September 11, 2019
    Publication date: March 19, 2020
    Inventors: Stephen J Demarest, Anja Koester, Scott Charles Potter, Diana Isabel Ruiz, Derrick Ryan Witcher, Xiufeng Wu, Payal Mehta